{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:49:48Z","timestamp":1792889388869,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.joim.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T14:31:07Z","timestamp":1632839467000},"page":"478-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications"],"prefix":"10.1016","volume":"19","author":[{"given":"Rakhi","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnendu","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1872-2075(08)60007-2","article-title":"Structure and function of angiotensin converting enzyme and its inhibitors","volume":"24","author":"Zhao","year":"2008","journal-title":"Chin J Biotechnol"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40256-016-0173-4","article-title":"Unraveling the pivotal role of bradykinin in ACE inhibitor activity","volume":"16","author":"Taddei","year":"2016","journal-title":"Am J of Cardiovasc Drugs"},{"issue":"14","key":"10.1016\/j.joim.2021.09.006_b0015","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: some old and new implications of ACE inhibition","volume":"33","author":"Hanif","year":"2010","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0025","first-page":"787","article-title":"The renin-angiotensin system and diabetes: an update","volume":"4","author":"Ribeiro-Oliveira","year":"2008","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0030","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","article-title":"Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus","volume":"6","author":"Tangvarasittichai","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.joim.2021.09.006_b0035","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.biopha.2018.09.058","article-title":"Molecular pathways associated with oxidative stress in diabetes mellitus","volume":"108","author":"Ighodaro","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0040","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/s41598-019-42700-1","article-title":"Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes","volume":"9","author":"Cho","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.joim.2021.09.006_b0045","series-title":"Molecular and cellular pharmacology","first-page":"547","article-title":"Mode of action of angiotensin converting enzyme inhibitors","author":"Burrell","year":"1997"},{"key":"10.1016\/j.joim.2021.09.006_b0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.fitote.2019.02.033","article-title":"Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets","volume":"134","author":"He","year":"2019","journal-title":"Fitoterapia"},{"key":"10.1016\/j.joim.2021.09.006_b0055","unstructured":"Rinayanti A, Radji M, Mun\u2019im A, Suyatna FD. Screening angiotensin converting enzyme (ACE) inhibitor activity of antihypertensive medicinal plants from Indonesia. Int J Pharm Teach Pract 2013; 4(1): 527\u201332."},{"issue":"9","key":"10.1016\/j.joim.2021.09.006_b0060","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.3390\/molecules25092114","article-title":"An overview of the potential use of ethno-medicinal plants targeting the renin-angiotensin system in the treatment of hypertension","volume":"25","author":"De Lange-Jacobs","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1078\/0944-7113-00003","article-title":"Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants","volume":"8","author":"Lacaille-Dubois","year":"2001","journal-title":"Phytomedicine"},{"key":"10.1016\/j.joim.2021.09.006_b0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fphar.2015.00323","article-title":"Anti-hypertensive herbs and their mechanisms of action: part I","volume":"6","author":"Al Disi","year":"2016","journal-title":"Front Pharmacol"},{"issue":"12A","key":"10.1016\/j.joim.2021.09.006_b0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0002-9149(03)00432-6","article-title":"Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease","volume":"91","author":"McFarlane","year":"2003","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1751-7176.2011.00449.x","article-title":"Renin-angiotensin-aldosterone system in diabetes and hypertension","volume":"13","author":"Hsueh","year":"2011","journal-title":"J Clin Hypertens"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0085","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbadis.2016.07.019","article-title":"The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance","volume":"1863","author":"Ramalingam","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4239\/wjd.v1.i5.141","article-title":"Role of the renin angiotensin system in diabetic nephropathy","volume":"1","author":"Chawla","year":"2010","journal-title":"World J Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.joim.2021.09.006_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mce.2012.05.017","article-title":"Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act","volume":"378","author":"Muniyappa","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/157016106775203126","article-title":"Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature","volume":"4","author":"Nakashima","year":"2006","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.joim.2021.09.006_b0105","doi-asserted-by":"crossref","first-page":"3634948","DOI":"10.1155\/2016\/3634948","article-title":"Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders","volume":"2016","author":"Janus","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"11","key":"10.1016\/j.joim.2021.09.006_b0110","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int J Biol Sci"},{"issue":"7","key":"10.1016\/j.joim.2021.09.006_b0115","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1083\/jcb.201802095","article-title":"The cell biology of systemic insulin function","volume":"217","author":"Tokarz","year":"2018","journal-title":"J Cell Biol"},{"issue":"9","key":"10.1016\/j.joim.2021.09.006_b0120","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/js.2019-00065","article-title":"Hyperinsulinemia: an early indicator of metabolic dysfunction","volume":"3","author":"Thomas","year":"2019","journal-title":"J Endoc Soc"},{"key":"10.1016\/j.joim.2021.09.006_b0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fendo.2017.00329","article-title":"Promoting glucose transporter-4 vesicle trafficking along cytoskeletal tracks: PAK-ing them out","volume":"8","author":"Tunduguru","year":"2017","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/dmrr.611","article-title":"The multi-faceted cross-talk between the insulin and angiotensin II signaling systems","volume":"22","author":"Velloso","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0135","first-page":"1","article-title":"Link between insulin resistance and hypertension: what is the evidence from evolutionary biology?","volume":"6","author":"Zhou","year":"2014","journal-title":"Diabetol Metab Synd"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/erc.11.182","article-title":"HDL dysfunction in diabetes: causes and possible treatments","volume":"10","author":"Farbstein","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/CS20050067","article-title":"NADPH oxidase and endothelial cell function","volume":"109","author":"Ray","year":"2005","journal-title":"Clin Sci"},{"key":"10.1016\/j.joim.2021.09.006_b0150","doi-asserted-by":"crossref","first-page":"9570616","DOI":"10.1155\/2019\/9570616","article-title":"Advanced glycation end products: potential mechanism and therapeutic target in cardiovascular complications under diabetes","volume":"2019","author":"Yang","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"10.1016\/j.joim.2021.09.006_b0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jcjd.2020.03.010","article-title":"Angiotensin II induces increased myocardial expression of receptor for advanced glycation end products (RAGE), monocyte\/macrophage infiltration and circulating endothelin-1 in rats with experimental diabetes","volume":"44","author":"Mu\u00f1oz","year":"2020","journal-title":"Can J Diabetes"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/gfg1036","article-title":"Role of angiotensin II in the progression of diabetic nephropathy\u2014therapeutic implications","volume":"18","author":"Wiecek","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0165","first-page":"575","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.joim.2021.09.006_b0170","series-title":"Angiotensin converting enzyme inhibitors (ACEI)","author":"Herman","year":"2020"},{"issue":"9","key":"10.1016\/j.joim.2021.09.006_b0175","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/14656566.2017.1328054","article-title":"A review of chemical therapies for treating diabetic hypertension","volume":"18","author":"Sarafidis","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.joim.2021.09.006_b0180","doi-asserted-by":"crossref","unstructured":"Heart Outcomes Prevention Evaluation Study Investigators; Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. New Engl J Med 2000; 342(3): 145\u201353.","DOI":"10.1056\/NEJM200001203420301"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0185","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ajh.2011.8","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials","volume":"24","author":"Tocci","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.joim.2021.09.006_b0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13300-016-0167-x","volume":"7","author":"Schofield","year":"2016","journal-title":"Diabetes dyslipidemia. Diabetes Ther"},{"issue":"13","key":"10.1016\/j.joim.2021.09.006_b0195","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2165\/00003495-200161130-00001","article-title":"Role of ACE inhibitors in patients with diabetes mellitus","volume":"61","author":"Cordonnier","year":"2001","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.joim.2021.09.006_b0200","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1681\/ASN.2005060595","article-title":"Angiotensin-converting enzyme inhibition in diabetic nephropathy: it\u2019s all the RAGE","volume":"16","author":"Harris","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.joim.2021.09.006_b0205","doi-asserted-by":"crossref","first-page":"17473","DOI":"10.1002\/jcp.28369","article-title":"Angiotensin-converting enzyme inhibitors attenuated advanced glycation end products-induced renal tubular hypertrophy via enhancing nitric oxide signaling","volume":"234","author":"Hwang","year":"2019","journal-title":"J Cell Physiol"},{"issue":"12","key":"10.1016\/j.joim.2021.09.006_b0210","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/00004872-200412000-00003","article-title":"Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system","volume":"22","author":"Kurtz","year":"2004","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cpt.455","article-title":"Improved insulin sensitivity with angiotensin receptor neprilysin inhibition in individuals with obesity and hypertension","volume":"101","author":"Jordan","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2165\/00002018-199207010-00004","article-title":"Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update","volume":"7","author":"Parish","year":"1992","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0225","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/md8041080","article-title":"Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry","volume":"8","author":"Wijesekara","year":"2010","journal-title":"Mar Drugs"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0230","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.drudis.2020.01.008","article-title":"Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities","volume":"25","author":"Raval","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.joim.2021.09.006_b0235","series-title":"Cardiac drug therapy","first-page":"85","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers","author":"Khan","year":"2007"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0240","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archinte.1994.00420050059006","article-title":"Angiotensin-converting enzyme inhibitors in hypertension. A dozen years of experience","volume":"154","author":"Materson","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.joim.2021.09.006_b0245","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00012995-200724600-00001","article-title":"Adverse effects of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in pregnancy","volume":"246","author":"Branch","year":"2007","journal-title":"Adverse Drug React Bull"},{"key":"10.1016\/j.joim.2021.09.006_b0250","doi-asserted-by":"crossref","unstructured":"Jao CL, Huang SL, Hsu KC. Angiotensin I-converting enzyme inhibitory peptides: inhibition mode, bioavailability, and antihypertensive effects. BioMedicine 2012; 2(4): 130\u20136","DOI":"10.1016\/j.biomed.2012.06.005"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037077","article-title":"Inhibition mechanism and model of an angiotensin I-converting enzyme (ACE)-inhibitory hexapeptide from yeast (Saccharomyces cerevisiae)","volume":"7","author":"Ni","year":"2012","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.joim.2021.09.006_b0260","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1021\/jf020482t","article-title":"Angiotensin I-converting enzyme inhibitory peptides derived from wakame (Undaria pinnatifida) and their antihypertensive effect in spontaneously hypertensive rats","volume":"50","author":"Sato","year":"2002","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.joim.2021.09.006_b0265","series-title":"Natural products targeting clinically relevant enzymes","first-page":"45","article-title":"Natural angiotensin converting enzyme (ACE) inhibitors with antihypertensive properties","author":"Margalef","year":"2017"},{"issue":"48","key":"10.1016\/j.joim.2021.09.006_b0270","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1021\/jf404641v","article-title":"Angiotensin-converting enzyme inhibitory effects by plant phenolic compounds: a study of structure activity relationships","volume":"61","author":"Al Shukor","year":"2013","journal-title":"J Agric Food Chem"},{"issue":"9","key":"10.1016\/j.joim.2021.09.006_b0275","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1039\/C7FO00212B","article-title":"Profiles of free and bound phenolics extracted from Citrus fruits and their roles in biological systems: content and antioxidant, anti-diabetic and anti-hypertensive properties","volume":"8","author":"Alu\u2019Datt","year":"2017","journal-title":"Food Funct"},{"key":"10.1016\/j.joim.2021.09.006_b0280","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.phytol.2015.04.021","article-title":"Structure-activity relationship and inhibition pattern of reishi-derived (Ganoderma lingzhi) triterpenoids against angiotensin-converting enzyme","volume":"12","author":"Hai-Bang","year":"2015","journal-title":"Phytochem Lett"},{"issue":"9","key":"10.1016\/j.joim.2021.09.006_b0285","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1248\/cpb.32.3615","article-title":"Inhibitors of angiotensin converting enzyme in crude drugs. I","volume":"32","author":"Inokuchi","year":"1984","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0290","first-page":"51","article-title":"Screening of plant materials for the inhibitory activities against angiotensin converting enzyme","volume":"12","author":"Yun","year":"1981","journal-title":"Kor J Pharmacog"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0295","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-8741(95)01286-M","article-title":"In vitro screening of traditional medicines for anti-hypertensive effect based on inhibition of the angiotensin converting enzyme (ACE)","volume":"48","author":"Hansen","year":"1995","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"10.1016\/j.joim.2021.09.006_b0300","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/10408390802145344","article-title":"Garlic: nature\u2019s protection against physiological threats","volume":"49","author":"Butt","year":"2009","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0305","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ptr.2579","article-title":"Inhibitory activities of Cassia tora and its anthraquinone constituents on angiotensin-converting enzyme","volume":"23","author":"Hyun","year":"2009","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0310","first-page":"769","article-title":"Hypotensive, angiotensin converting enzyme (ACE) inhibitory and diuretic activities of the aqueous-methanol extract of Ipomoea reniformis","volume":"12","author":"Jabeen","year":"2013","journal-title":"Iran J Pharm Res"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0315","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.apsb.2013.07.003","article-title":"Chemical constituents and ACE inhibitory activity of desert plant Suaeda physophora Pall","volume":"3","author":"Men","year":"2013","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"10.1016\/j.joim.2021.09.006_b0320","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3109\/13880209.2010.490223","article-title":"Antioxidant and angiotensin converting enzyme (ACE) inhibitory activities of ethanol extract and pure flavonoids from Adinandra nitida leaves","volume":"48","author":"Liu","year":"2010","journal-title":"Pharm Biol"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0325","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jep.2012.09.038","article-title":"Antihypertensive activity of Rosa rugosa Thunb. flowers: angiotensin I converting enzyme inhibitor","volume":"144","author":"Xie","year":"2012","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0330","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jep.2010.12.026","article-title":"Antihypertensive effects of isoquercitrin and extracts from Tropaeolum majus L.: evidence for the inhibition of angiotensin converting enzyme","volume":"134","author":"Gasparotto Junior","year":"2011","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0335","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/2008-2231-21-74","article-title":"Discovery of new angiotensin converting enzyme (ACE) inhibitors from medicinal plants to treat hypertension using an in vitro assay","volume":"21","author":"Sharifi","year":"2013","journal-title":"DARU J Pharm Sci"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0340","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s12906-016-1421-5","article-title":"In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes","volume":"16","author":"Deo","year":"2016","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.joim.2021.09.006_b0345","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.foodchem.2014.05.080","article-title":"Identification of a new angiotensin-converting enzyme (ACE) inhibitor from Thai edible plants","volume":"165","author":"Simaratanamongkol","year":"2014","journal-title":"Food Chem"},{"key":"10.1016\/j.joim.2021.09.006_b0350","doi-asserted-by":"crossref","first-page":"4643736","DOI":"10.1155\/2018\/4643736","article-title":"Identification of hypotensive biofunctional compounds of Coriandrum sativum and evaluation of their angiotensin-converting enzyme (ACE) inhibition potential","volume":"2018","author":"Hussain","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"1\u20133","key":"10.1016\/j.joim.2021.09.006_b0355","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-8741(99)00097-5","article-title":"Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors","volume":"68","author":"Duncan","year":"1999","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0360","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3177\/jnsv.45.375","article-title":"Effects of angiotensin I-converting enzyme inhibitor from Ashitaba (Angelica keiskei) on blood pressure of spontaneously hypertensive rats","volume":"45","author":"Shimizu","year":"1999","journal-title":"J Nutr Sci Vitaminol"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0365","first-page":"13","article-title":"Investigation of angiotensin converting enzyme inhibitory effects of medicinal plants used in traditional Persian medicine for treatment of hypertension: screening study","volume":"1","author":"Kouchmeshky","year":"2012","journal-title":"Thrita Stud J Med Sci"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0370","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-8741(97)00100-1","article-title":"Plants from R\u00e9union island with alleged antihypertensive and diuretic effects\u2014an experimental and ethnobotanical evaluation","volume":"58","author":"Adsersen","year":"1997","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.joim.2021.09.006_b0375","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.enzmictec.2018.10.010","article-title":"Evaluation of angiotensin converting enzyme inhibitors by SPR biosensor and theoretical studies","volume":"120","author":"Salehabadi","year":"2019","journal-title":"Enzyme Microb Technol"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-8741(97)00158-X","article-title":"Ethnomedicinal information and in vitro screening for angiotensin-converting enzyme inhibition of plants utilized as traditional medicines in Gujarat, Rajasthan and Kerala (India)","volume":"60","author":"Nyman","year":"1998","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0385","first-page":"77","article-title":"In vitro inhibitory potential of selected Malaysian plants against key enzymes involved in hyperglycemia and hypertension","volume":"17","author":"Loh","year":"2011","journal-title":"Malays J Nutr"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0390","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1080\/13880209.2017.1307421","article-title":"Selection of chemical markers for the quality control of medicinal plants of the genus Cecropia","volume":"55","author":"Rivera-Mondrag\u00f3n","year":"2017","journal-title":"Pharm Biol"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0395","first-page":"671","article-title":"Angiotensin converting enzyme inhibition activity of fennel and coriander oils from India","volume":"8","author":"Chaudhary","year":"2013","journal-title":"Nat Prod Commun"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0400","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0944-7113(00)80011-2","article-title":"Screening the Brazilian flora for antihypertensive plant species for in vitro angiotensin-I-converting enzyme inhibiting activity","volume":"7","author":"Castro Braga","year":"2000","journal-title":"Phytomedicine"},{"issue":"3\u20134","key":"10.1016\/j.joim.2021.09.006_b0405","first-page":"22","article-title":"In vitro assays of anti-diabetic and anti-hypertensive potential of some traditional edible plants of Qatar","volume":"4","author":"Phoboo","year":"2015","journal-title":"J Med Active Plants"},{"issue":"10","key":"10.1016\/j.joim.2021.09.006_b0410","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1055\/s-2004-832617","article-title":"Compounds from Epilobium angustifolium inhibit the specific metallopeptidases ACE, NEP and APN","volume":"70","author":"Kiss","year":"2004","journal-title":"Planta Med"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0415","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jep.2011.04.059","article-title":"Yuan L. In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension","volume":"136","author":"Wu","year":"2011","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0420","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5530\/pj.2017.2.43","article-title":"Inhibition activity of angiotensin converting enzyme (ACE) and determination of total phenolic and flavonoid compound from bitter melon leaves (Momordica charantia L.)","volume":"9","author":"Lestari","year":"2017","journal-title":"Pharmacogn J"},{"issue":"11","key":"10.1016\/j.joim.2021.09.006_b0425","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3109\/13880209.2014.996820","article-title":"Angiotensin-converting enzyme (ACE) inhibitory potential of standardized Mucuna pruriens seed extract","volume":"53","author":"Chaudhary","year":"2015","journal-title":"Pharm Biol"},{"key":"10.1016\/j.joim.2021.09.006_b0430","doi-asserted-by":"crossref","first-page":"166","DOI":"10.22159\/ajpcr.2017.v10s5.23123","article-title":"Angiotensin I-converting enzyme inhibitory activity, total phenolic and flavonoid content of extract and fraction of jam fruit leaves (Muntingia calabura L.)","volume":"10","author":"Lasboi","year":"2017","journal-title":"Asian J Pharm Clin Res"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0435","first-page":"1054","article-title":"Inhibition of angiotensin converting enzyme (ACE) activity by some Indonesia edible plants","volume":"6","author":"Saputri","year":"2015","journal-title":"Int J Pharm Sci Res"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0440","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jep.2013.05.046","article-title":"Isolation, identification and molecular docking studies of a new isolated compound, from Onopordon acanthium: a novel angiotensin converting enzyme (ACE) inhibitor","volume":"148","author":"Sharifi","year":"2013","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0445","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.lwt.2009.11.005","article-title":"The antioxidant, angiotensin converting enzyme inhibition activity, and phenolic compounds of bamboo shoot extracts","volume":"43","author":"Park","year":"2010","journal-title":"LWT Food Sci Technol"},{"issue":"7","key":"10.1016\/j.joim.2021.09.006_b0450","first-page":"1361","article-title":"Evaluation of prunes for hypotensive, angiotensin converting enzyme (ACE) inhibitory and diuretic activities in rats","volume":"6","author":"Jabeen","year":"2012","journal-title":"J Med Plants Res"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0455","doi-asserted-by":"crossref","first-page":"e0213493","DOI":"10.1371\/journal.pone.0213493","article-title":"Antioxidant, antihypertensive, anti-hyperglycemic, and antimicrobial activity of aqueous extracts from twelve native plants of the Yucatan coast","volume":"14","author":"Rodr\u00edguez-Garc\u00eda","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.joim.2021.09.006_b0460","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s13596-012-0076-0","article-title":"ACE inhibition activity of standardized extract and fractions of Terminalia bellerica","volume":"12","author":"Chaudhary","year":"2012","journal-title":"Orient Pharm Exp Med"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0465","first-page":"5","article-title":"Inhibition of angiotensin converting enzyme (ACE) by Viola mandshurica extraction","volume":"3","author":"Huh","year":"2015","journal-title":"Eur J Adv Res Biol Life Sci"},{"key":"10.1016\/j.joim.2021.09.006_b0470","series-title":"Bioactive food peptides in health and disease","first-page":"145","article-title":"Antihypertensive properties of plant protein derived peptides","author":"Pihlanto","year":"2013"},{"issue":"21","key":"10.1016\/j.joim.2021.09.006_b0475","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1021\/jf0203287","article-title":"Both dioscorin, the tuber storage protein of yam (Dioscorea alata cv. Tainong No. 1), and its peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activities","volume":"50","author":"Hsu","year":"2002","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.joim.2021.09.006_b0480","first-page":"257","article-title":"Sweet potato storage root defensin and its tryptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro","volume":"52","author":"Huang","year":"2011","journal-title":"Bot Stud"},{"key":"10.1016\/j.joim.2021.09.006_b0485","first-page":"15","article-title":"Sweet potato storage root thioredoxin h2 and their peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro","volume":"52","author":"Huang","year":"2011","journal-title":"Bot Stud"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0490","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.foodchem.2007.12.023","article-title":"ACE-inhibitory and antioxidant properties of potato (Solanum tuberosum)","volume":"109","author":"Pihlanto","year":"2008","journal-title":"Food Chem"},{"issue":"12","key":"10.1016\/j.joim.2021.09.006_b0495","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1039\/C9FO02127B","article-title":"Angiotensin-converting enzyme inhibiting ability of ethanol extracts, steviol glycosides and protein hydrolysates from Stevia leaves","volume":"10","author":"Wang","year":"2019","journal-title":"Food Funct"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0500","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lwt.2008.05.003","article-title":"Purification of angiotensin converting enzyme inhibitory peptides from sunflower protein hydrolysates by reverse-phase chromatography following affinity purification","volume":"42","author":"Meg\u00edas","year":"2009","journal-title":"LWT Food Sci Technol"},{"issue":"8","key":"10.1016\/j.joim.2021.09.006_b0505","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1021\/jf4039056","article-title":"Optimization of the enzymatic hydrolysis of lupin (Lupinus) proteins for producing ACE-inhibitory peptides","volume":"62","author":"Boschin","year":"2014","journal-title":"J Agric Food Chem"},{"issue":"11","key":"10.1016\/j.joim.2021.09.006_b0510","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1039\/C6FO01132B","article-title":"Apricot and other seed stones: amygdalin content and the potential to obtain antioxidant, angiotensin I converting enzyme inhibitor and hypocholesterolemic peptides","volume":"7","author":"Garc\u00eda","year":"2016","journal-title":"Food Funct"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0515","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.foodchem.2011.09.038","article-title":"Hypotensive effect of a sweet potato protein digest in spontaneously hypertensive rats and purification of angiotensin I-converting enzyme inhibitory peptides","volume":"131","author":"Ishiguro","year":"2012","journal-title":"Food Chem"},{"issue":"17","key":"10.1016\/j.joim.2021.09.006_b0520","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1021\/jf026186y","article-title":"Isolation and antihypertensive effect of angiotensin I-converting enzyme (ACE) inhibitory peptides from spinach Rubisco","volume":"51","author":"Yang","year":"2003","journal-title":"J Agric Food Chem"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0525","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.procbio.2008.12.017","article-title":"Purification and identification of an angiotensin I-converting enzyme inhibitory peptide from fermented soybean extract","volume":"44","author":"Rho","year":"2009","journal-title":"Process Biochem"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0530","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nutres.2007.01.012","article-title":"Ingestion of Apios americana Medikus tuber suppresses blood pressure and improves plasma lipids in spontaneously hypertensive rats","volume":"27","author":"Iwai","year":"2007","journal-title":"Nutr Res"},{"issue":"6","key":"10.1016\/j.joim.2021.09.006_b0535","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0196-9781(03)00174-8","article-title":"New antihypertensive peptides isolated from rapeseed","volume":"24","author":"Marczak","year":"2003","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.joim.2021.09.006_b0540","first-page":"1318","article-title":"Characterization of antihypertensive angiotensin I-converting enzyme inhibitor from Saccharomyces cerevisiae","volume":"14","author":"Kim","year":"2004","journal-title":"J Microb Biotechnol"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0545","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10942912.2010.503357","article-title":"Antioxidant, antidiabetic, and antihypertensive effects of extracted phenolics and hydrolyzed peptides from barley protein fractions","volume":"15","author":"Alu\u2019datt","year":"2012","journal-title":"Int J Food Prop"},{"issue":"6","key":"10.1016\/j.joim.2021.09.006_b0550","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.peptides.2010.02.022","article-title":"Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship","volume":"31","author":"Jimsheena","year":"2010","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0555","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4014\/jmb.1109.09015","article-title":"Characterization of new antihypertensive angiotensin I-converting enzyme inhibitory peptides from Korean traditional rice wine","volume":"22","author":"Kang","year":"2012","journal-title":"J Microb Biotechnol"},{"issue":"8","key":"10.1016\/j.joim.2021.09.006_b0560","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s12010-012-9630-y","article-title":"Angiotensin I-converting enzyme inhibitory proteins and peptides from the rhizomes of Zingiberaceae plants","volume":"166","author":"Yodjun","year":"2012","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.joim.2021.09.006_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112724","article-title":"Anti-hypertensive and angiotensin-converting enzyme inhibitory effects of Radix astragali and its bioactive peptide AM-1","volume":"254","author":"Wu","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.joim.2021.09.006_b0570","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.foodchem.2013.10.053","article-title":"Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (J.E. Lange) Imbach identified by LC-MS\/MS","volume":"148","author":"Lau","year":"2014","journal-title":"Food Chem"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0575","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/10942912.2012.716476","article-title":"Separation, purification, and identification of angiotensin I-converting enzyme inhibitory peptides from walnut (Juglans regia L.) hydrolyzate","volume":"18","author":"Gu","year":"2015","journal-title":"Int J Food Prop"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0580","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/jf903515f","article-title":"Flavonoids from the buds of Rosa damascena inhibit the activity of 3-hydroxy-3-methylglutaryl-coenzyme a reductase and angiotensin I-converting enzyme","volume":"58","author":"Kwon","year":"2010","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0585","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jep.2009.09.059","article-title":"Inhibition of angiotensin converting enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa","volume":"127","author":"Ojeda","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.joim.2021.09.006_b0590","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00833411","article-title":"In vitro screening of angiotensin I-converting enzyme inhibitors from Japanese cedar (Cryptomeria japonica)","volume":"44","author":"Tsutsumi","year":"1998","journal-title":"J Wood Sci"},{"issue":"12","key":"10.1016\/j.joim.2021.09.006_b0595","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0024-3205(03)00481-8","article-title":"Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiontensin converting enzyme","volume":"73","author":"Liu","year":"2003","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0600","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s11418-017-1095-4","article-title":"Phytochemical profile and angiotensin I converting enzyme (ACE) inhibitory activity of Limonium michelsonii Lincz","volume":"71","author":"Jenis","year":"2017","journal-title":"J Nat Med"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0605","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.phymed.2009.09.008","article-title":"ACE inhibition by astilbin isolated from Erythroxylum gonocladum (Mart.) O.E","volume":"17","author":"Lucas-Filho","year":"2010","journal-title":"Schulz. Phytomedicine"},{"issue":"11","key":"10.1016\/j.joim.2021.09.006_b0610","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/molecules21111500","article-title":"Flavonoids-rich Orthosiphon stamineus extract as new candidate for angiotensin I-converting enzyme inhibition: a molecular docking study","volume":"21","author":"Shafaei","year":"2016","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0615","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jep.2008.06.003","article-title":"In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes","volume":"119","author":"Loizzo","year":"2008","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"10.1016\/j.joim.2021.09.006_b0620","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/ptr.1199","article-title":"Four glycosides from the leaves of Abeliophyllum distichum with inhibitory effects on angiotensin converting enzyme","volume":"17","author":"Oh","year":"2003","journal-title":"Phytother Res"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0625","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.phymed.2007.09.013","article-title":"Three angiotensin-converting enzyme inhibitors from Rabdosia coetsa","volume":"15","author":"Li","year":"2008","journal-title":"Phytomedicine"},{"issue":"1\u20132","key":"10.1016\/j.joim.2021.09.006_b0630","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-8741(02)00216-7","article-title":"Angiotensin converting enzyme inhibitors from Cuscuta japonica Choisy","volume":"83","author":"Oh","year":"2002","journal-title":"J Ethnopharmacol"},{"issue":"29","key":"10.1016\/j.joim.2021.09.006_b0635","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1021\/jf3022157","article-title":"Activity-guided discovery of (S)-malic acid 1\u2032-O-\u03b2-gentiobioside as an angiotensin I-converting enzyme inhibitor in lettuce (Lactuca sativa)","volume":"60","author":"Lagemann","year":"2012","journal-title":"J Agric Food Chem"},{"issue":"12","key":"10.1016\/j.joim.2021.09.006_b0640","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1248\/bpb.27.2035","article-title":"Isolation of angiotensin converting enzyme (ACE) inhibitory flavonoids from Sedum sarmentosum","volume":"27","author":"Oh","year":"2004","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0645","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0944-7113(96)80075-4","article-title":"Angiotensin converting enzyme (ACE) inhibitory flavonoids from Erythroxylum laurifolium","volume":"2","author":"Hansen","year":"1996","journal-title":"Phytomedicine"},{"issue":"57","key":"10.1016\/j.joim.2021.09.006_b0650","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.4103\/pm.pm_325_17","article-title":"Angiotensin-converting enzyme inhibitory activity of Senna garrettiana active compounds: potential markers for standardized herbal medicines","volume":"14","author":"Madaka","year":"2018","journal-title":"Pharmacogn Mag"},{"key":"10.1016\/j.joim.2021.09.006_b0655","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.fitote.2016.12.001","article-title":"Megastigmane glycosides from leaves of Eucommia ulmoides Oliver with ACE inhibitory activity","volume":"116","author":"Yan","year":"2017","journal-title":"Fitoterapia"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0660","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3136\/fstr.20.711","article-title":"Angiotensin I-converting enzyme (ACE) inhibitory activity of ursolic acid isolated from Thymus vulgaris L","volume":"20","author":"Shimada","year":"2014","journal-title":"Food Sci Technol Res"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0665","first-page":"381","article-title":"The potential angiotensin-converting enzyme inhibitory activity of oleanolic acid in the hydroethanolic extract of Crataegus monogyna Jacq","volume":"1","author":"Attard","year":"2006","journal-title":"Nat Prod Commun"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0670","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/10496475.2012.736925","article-title":"Angiotensin-converting enzyme inhibitory potential of harmaline isolated from Peganum harmala L. seeds","volume":"19","author":"Hivrale","year":"2013","journal-title":"J Herbs Spices Med Plants"},{"issue":"6","key":"10.1016\/j.joim.2021.09.006_b0675","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1537-1891(03)00005-3","article-title":"Effects of berberine on angiotensin-converting enzyme and NO\/cGMP system in vessels","volume":"39","author":"Kang","year":"2002","journal-title":"Vasc Pharmacol"},{"issue":"6","key":"10.1016\/j.joim.2021.09.006_b0680","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1055\/s-2003-40659","article-title":"Angiotensin converting enzyme (ACE) inhibitory alkaloids from Fritillaria ussuriensis","volume":"69","author":"Oh","year":"2003","journal-title":"Planta Med"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0685","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fitote.2009.08.012","article-title":"Puqienine E: an angiotensin converting enzyme inhibitory steroidal alkaloid from Fritillaria puqiensis","volume":"81","author":"An","year":"2010","journal-title":"Fitoterapia"},{"issue":"38","key":"10.1016\/j.joim.2021.09.006_b0690","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0973-1296.131021","article-title":"ACE and platelet aggregation inhibitors from Tamarix hohenackeri Bunge (host plant of Herba Cistanches) growing in Xinjiang","volume":"10","author":"Xing","year":"2014","journal-title":"Pharmacogn Mag"},{"issue":"5","key":"10.1016\/j.joim.2021.09.006_b0695","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.3390\/molecules18055389","article-title":"Curcumin and its carbocyclic analogs: structure-activity in relation to antioxidant and selected biological properties","volume":"18","author":"Bhullar","year":"2013","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.joim.2021.09.006_b0700","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.3390\/molecules24213937","article-title":"Angiotensin-I-converting enzyme inhibitory activity of coumarins from Angelica decursiva","volume":"24","author":"Ali","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0705","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jep.2011.06.031","article-title":"Hancornia speciosa Gomes induces hypotensive effect through inhibition of ACE and increase on NO","volume":"137","author":"Silva","year":"2011","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0710","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5567\/sciintl.2013.2.12","article-title":"South Asian herbal plants as anti-hypertensive agents\u2014a review","volume":"1","author":"Munir","year":"2013","journal-title":"Sci Int"},{"key":"10.1016\/j.joim.2021.09.006_b0715","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13596-015-0188-4","article-title":"Evaluation of inhibitory affinity potential of the alkaloids against crystal structure of human angiotensin-converting enzyme using Lamarckian genetic algorithm","volume":"15","author":"Madeswaran","year":"2015","journal-title":"Orient Pharm Exp Med"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0720","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1532-0456(00)00172-1","article-title":"Antihypertensive effect of ACE inhibitory oligopeptides from chicken egg yolks","volume":"128","author":"Yoshii","year":"2001","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10.1016\/j.joim.2021.09.006_b0725","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/ijfs.13681","article-title":"Effect of seaweed flakes addition on the development of bioactivities in functional Camembert-type cheese","volume":"53","author":"Hell","year":"2018","journal-title":"Int J Food Sci Technol"},{"issue":"1","key":"10.1016\/j.joim.2021.09.006_b0730","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2006-957065","article-title":"Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial","volume":"73","author":"Herrera-Arellano","year":"2007","journal-title":"Planta Med"},{"issue":"9","key":"10.1016\/j.joim.2021.09.006_b0735","first-page":"319","article-title":"Antihypertensive and diuretic action of Adathodai Ilai Chooranam\u2014a Siddha mono-herbal formulation","volume":"5","author":"Selvakumar","year":"2018","journal-title":"Eur J Biomed Pharm Sci"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0740","first-page":"42","article-title":"Effects of Ginkgo biloba extract EGb 761 and its terpenelactones on angiotensin converting enzyme activity and nitric oxide production in human endothelial cells","volume":"3","author":"Persson","year":"2008","journal-title":"J Trad Med"},{"issue":"7","key":"10.1016\/j.joim.2021.09.006_b0745","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.18203\/2319-2003.ijbcp20182694","article-title":"The effect of a polyherbal oral formulation in the management of essential hypertension: an open label, pilot clinical study","volume":"7","author":"Sane","year":"2018","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090807","article-title":"Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-\u03b2\/Smad3 signaling","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.joim.2021.09.006_b0755","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jep.2018.10.004","article-title":"Effects and mechanisms of Danshen-Shanzha herb-pair for atherosclerosis treatment using network pharmacology and experimental pharmacology","volume":"229","author":"Zhang","year":"2019","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0760","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/13102818.2014.911611","article-title":"Chinese medicinal formula Fufang Xueshuantong capsule could inhibit the activity of angiotensin converting enzyme","volume":"28","author":"Sheng","year":"2014","journal-title":"Biotechnol Biotechnol Equip"},{"key":"10.1016\/j.joim.2021.09.006_b0765","first-page":"7056872","article-title":"Effects of 12-week supplementation of a polyherbal formulation in old adults with prehypertension\/hypertension: a randomized, double-blind, placebo-controlled trial","volume":"2019","author":"Shen","year":"2019","journal-title":"Evid Based Compl Altern Med"},{"key":"10.1016\/j.joim.2021.09.006_b0770","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bcab.2016.08.015","article-title":"Angiotensin-I converting enzyme inhibitory activity of mushroom Lentinus polychrous L\u00e9v. and its development of healthy drink recipes","volume":"8","author":"Kokram","year":"2016","journal-title":"Biocatal Agric Biotechnol"},{"issue":"4","key":"10.1016\/j.joim.2021.09.006_b0775","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4103\/0974-8520.159034","article-title":"Evaluation of polyherbal formulation (SJT-HT-03) for antihypertensive activity in albino rats","volume":"35","author":"Ghelani","year":"2014","journal-title":"Ayu"},{"key":"10.1016\/j.joim.2021.09.006_b0780","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.foodchem.2018.06.114","article-title":"Study of soy-fortified green tea curd formulated using potential hypocholesterolemic and hypotensive probiotics isolated from locally made curd","volume":"268","author":"Moumita","year":"2018","journal-title":"Food Chem"},{"key":"10.1016\/j.joim.2021.09.006_b0785","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jep.2017.12.011","article-title":"Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure","volume":"219","author":"Chen","year":"2018","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0790","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1590\/S0102-695X2013005000018","article-title":"Herbal medicines: old and new concepts, truths and misunderstandings","volume":"23","author":"Carmona","year":"2013","journal-title":"Braz J Pharmacogn"},{"key":"10.1016\/j.joim.2021.09.006_b0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119288","article-title":"Bioactive glasses meet phytotherapeutics: the potential of natural herbal medicines to extend the functionality of bioactive glasses","volume":"217","author":"Schuhladen","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.joim.2021.09.006_b0800","article-title":"New perspectives on how to discover drugs from herbal medicines: CAM\u2019s outstanding contribution to modern therapeutics","volume":"2013","author":"Pan","year":"2013","journal-title":"Evid Based Compl Altern Med"},{"key":"10.1016\/j.joim.2021.09.006_b0805","series-title":"Phytochemistry: an in silico and in vitro update","first-page":"3","article-title":"Phytochemicals as sources of drugs","author":"Ezzat","year":"2019"},{"issue":"3","key":"10.1016\/j.joim.2021.09.006_b0810","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/01480545.2016.1212366","article-title":"Fetopathies associated with exposure to angiotensin converting enzyme inhibitor from Tropaeolum majus L","volume":"40","author":"Botelho Louren\u00e7o","year":"2017","journal-title":"Drug Chem Toxicol"},{"issue":"2","key":"10.1016\/j.joim.2021.09.006_b0815","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-8741(98)00201-3","article-title":"An ethnopharmacological survey for potential angiotension converting enzyme inhibitors from Indian medicinal plants","volume":"65","author":"Somanadhan","year":"1999","journal-title":"J Ethnopharmacol"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496421000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496421000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:52:29Z","timestamp":1761864749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496421000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":163,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2095496421000856"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2021.09.006","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}